logo
logo

MTD successfully completes acquisition of Pen Needles and Blood Glucose Monitoring Systems business units of Ypsomed

Aug 02, 2024•12 months ago

Acquiring Company

MTD Group

Acquired Company

Ypsomed

MilanBurgdorfMedical DeviceMedicalBiotechnologyHealth CareManufacturingBiotechnologyManufacturing

Description

MTD announces the successful completion of the strategic acquisition of Pen Needles and Blood Glucose Monitoring Systems (BGM) business units from Ypsomed. This acquisition strengthens MTD's position as the clear number two in the world market for pen needles, expands its product portfolio, and facilitates entry into high-growth markets like China and India.

Company Information

Company

MTD Group

Location

Milan, Lombardy, Italy

About

Medical Technology and Devices (MTD) is a consumer health group owning a portfolio of global brands with leading position across Diabetes, Medical Sharps, Wound Care, Heart Monitors, Thermometers & Nebulizers. It owns PiC Solution in EMEA/APAC & Droplet in NA, iconic brands with up to 40+ years history and 90% of consumer awareness. The portfolio of products is distributed in 100+ markets - reaching half of global population – thanks to direct operations in Italy, US, France, Germany, India and reaching the rest via a long-established network of distributors.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Felipe hidden

Matteo hidden